SUMMARY:
In this study, we devised a multiplex PCR assay based on the gene of cytolethal distending toxin (cdt ) B subunit to simultaneously detect and discriminate Campylobacter jejuni, C. fetus, C. coli, C. upsaliensis, C. hyointestinalis, and C. lari. Species-specific PCR products were successfully obtained from all 38 C. jejuni, 12 C. fetus, 39 C. coli, 22 C. upsaliensis, 24 C. hyointestinalis, and 7 C. lari strains tested. On the other hand, no specific PCR products were obtained from other campylobacters and bacterial species tested (41 strains in total). The proposed multiplex PCR assay is a valuable tool for detection and descrimination of 6 major Campylobacter species, that are associated with gastrointestinal diseases in humans.
The genus Campylobacter currently comprises 25 species, 12 of which have been isolated or detected in patients with gastroenteritis (1). Among these 12 campylobacters, Campylobacter jejuni and C. coli are most frequently detected in human diarrheal stool specimens worldwide (2, 3) . Furthermore, campylobacters are also thought to be associated with extragastrointestinal manifestations, such as septicemia, reactive arthritis, hemolytic-uremic syndrome, and Guillain-Barr áe syndrome (1) .
Several culture methods fail to isolate some non-C. jejuni/C. coli strains because most of the culture methods are designed for isolation of C. jejuni and C. coli (1, 4) . For example, cephem antibiotics in the Butzler medium, Bolton broth, and modified charcoal cefoperazone deoxycholate agar (mCCDA) may suppress the growth of cephem-susceptible campylobacters, such as C. fetus, C. hyointestinalis, and C. upsaliensis (5). Indeed, non-C. jejuni/C. coli strains have been successfully isolated from patients with diarrhea by using non-selective media such as a combination of blood agar and a filter with pores 0.6 mm in diameter (4, 6) . If researchers could know which campylobacters are present in clinical samples before culturing, then it would be possible to select an appropriate culture method for isolation of the bacteria. Therefore, it is important to establish a simple and rapid method for detection and discrimination of Campylobacter species. We recently developed a PCR-restriction fragment length polymorphism (PCR-RFLP) assay to detect and discriminate 7 Campylobacter species (7) that are associated with human gastrointestinal diseases (1). However, sensitivity of the assay for C. hyointestinalis was not sufficient (7) . Therefore, in the present study, we developed and evaluated a multiplex PCR assay based on the gene of cytolethal distending toxin (cdt ) B subunit for C. jejuni, C. fetus, C. coli, C. upsaliensis, C. hyointestinalis, and C. lari.
A total of 149 Campylobacter strains and 34 nonCampylobacter strains were used in this study (Table 1 ). All the strains were cultured as described previously (7) or by the general protocol for culture of each bacterial species. Template DNA for the PCR assay was prepared by the boiling method as previously described (7) . Briefly, bacteria were grown on appropriate agar plates, and a loopful of the bacteria was suspended in 1 mL of TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH 8.0]), alternatively, 50 mL of a mid-log phase bacterial culture was added to 450 mL of TE buffer. The suspensions were 
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cdt Gene-Based Multiplex PCR for 6 Campylobacters boiled for 10 min, incubated on ice for 5 min, and centrifuged at 12,800 × g for 5 min. The supernatants were collected and stored at -209 C until use. Species-specific primers were designed on the basis of cdtB gene sequences of C. jejuni ATCC 33560 (GenBank accession number, AB274783), C. fetus ATCC 27374 (AB274802), C. coli ATCC 33559 (AB274793), C. upsaliensis ATCC 43954 (AB872889), C. hyointestinalis ATCC 35217 (AB373951), and C. lari ATCC 43675 (AB872911), and the primers are summarized in Table  2 . These bacteria served as reference strains. The 40 mL reaction mixture contained 1 mL of a template DNA (approximately 10 5 CFU/PCR tube), an appropriate concentration of 12 primers described in Table 2 , 0.2 mL of Multiplex PCR Mix 1 and 20 mL of Mix 2 (Takara Bio, Shiga, Japan). PCR was carried out by using Takara PCR Thermal Cycler (Takara Bio) or Applied Biosystems GeneAmp PCR 9700 (Life Technologies, Carlsbad, CA, USA). The samples were subjected to initial denaturation at 949 C for 1 min, followed by 30 amplification cycles, each consisting of 949 C for 30 s, 569 C for 90 s, and 729 C for 90 s. Final extension at 729 C for 5 min completed the reaction. PCR products were analyzed by electrophoresis in a 2.5z agarose gel, and the bands were visualized with UV light after staining with ethidium bromide. Images were captured on a Gel Doc system (Bio-Rad, Hercules, CA, USA).
As shown in Fig. 1 , the multiplex PCR with 6 primer pairs yielded a cdtB amplicon of 714 bp for C. jejuni, 553 bp for C. fetus, 433 bp for C. coli, 342 bp for C. upsaliensis, 215 bp of C. hyointestinalis, and 141 bp of C. lari strains. Because a species-specific PCR product was successfully obtained for all 142 strains belonging to the 6 Campylobacter species under the study (Table 1) , the sensitivity of our multiplex PCR assay was 100z. Furthermore, the species-specific DNA fragments were successfully amplified simultaneously from a mixture of all 6 bacterial templates (Fig. 1, lane 9) . On the other hand, no cdtB gene-specific PCR products were obtained (data not shown) when we tested other Campylobacter species, including C. helveticus, C. mucosalis, C. hominis, C. concisus and C. curvus, and non-Campylobacter strains (41 strains in total) descried in Table  1 , indicating that the multiplex PCR developed in this study has 100z specificity.
CDT is known to be a possible virulence factor of various Gram-negative pathogenic bacteria including Campylobacter spp. (8) and represents a tripartite toxin encoded by 3 adjacent genes: cdtA, cdtB, and cdtC. It has been reported that the cdt genes in campylobacters seem to be ubiquitously present in a species-specific manner (9) , and a cdt gene-based multiplex PCR assay was successfully developed for detection of C. jejuni, C. coli, and C. fetus (10) . Furthermore, we recently developed a cdtB gene-based PCR-RFLP assay for the detection and discrimination of C. jejuni, C. coli, C. fetus, C. hyointestinalis, C. lari, C. helveticus, and C. upsaliensis (7). However, PCR products failed to be amplified when we tested some C. hyointestinalis strains by the PCR-RFLP assay. Later, we demonstrated that 3 cdt variant genes (ch-cdt-I to ch-cdt-III ) are present in C. hyointestinalis, and only ch-cdt-II genes (not ch-cdt-I genes) are ubiquitously present in C. hyointestinalis strains (Hatanaka et al., submitted for publication and unpublished data). Since the PCR primer for the PCR-RFLP assay was designed on the basis of ch-cdt-IB gene, this PCR-RFLP assay could not detect the ch-cdt-I negative strains because of a primer mismatch (7) . In the present study, we designed primers for C. hyointes-tinalis on the basis of the ch-cdt-IIB gene. As expected, species-specific PCR products were successfully obtained for all the C. hyointestinalis strains tested by the multiplex PCR assay developed in this study (Table 1) . Moreover, multiplex PCR is simpler than PCR-RFLP. Therefore, the proposed multiplex PCR may be useful for rapid detection and discrimination of the 6 abovementioned Campylobacter species, which are clinically important for human diseases such as gastroenteritis and extragastrointestinal complications.
In conclusion, we demonstrated that the cdtB genebased multiplex PCR assay can detect C. jejuni, C. fetus, C. coli, C. hyointestinalis, C. upsaliensis, and C. lari with high sensitivity and specificity. Further evaluation of the multiplex PCR on various samples from humans and animals is required.
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